Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001385508-23-000011)

Filing Details

Accession Number:: 0001385508-23-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-05 17:03:45
Reporting Period:: 2023-01-05

Accepted Time:: 2023-01-05 17:03:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385508	Opiant Pharmaceuticals Inc.	OPNT	Pharmaceutical Preparations (2834)	464744124

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1491140	D David O'toole	C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Boulevard, Suite 400 Santa Monica CA 90401	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-05	1,600	$20.20	35,204	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.